NX-1607

· Nurix Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NX-1607, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]